Charles R. Kummeth - 15 Aug 2023 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Aug 2023, 16:14:54 UTC
Prior SEC filing
11 Aug 2023
Next SEC filing
20 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew Nick, as Attorney-in-Fact pursuant to Power of Attorney previously filed.

Key filing fact

Charles R. Kummeth filed Form 4 for BIO-TECHNE Corp (TECH) on 17 Aug 2023.

Key facts

  • This page summarizes Charles R. Kummeth's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 14 derivative rows are listed below.
  • Accepted by SEC: 17 Aug 2023, 16:14.

Change

  • Previous filing in this sequence was filed on 11 Aug 2023.
  • Current net transaction value: -$733,992.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+17,632
Change %
+1.4%
Price
$0.000000
Shares after
1,286,944
Date
15 Aug 2023
Ownership
Direct
Footnotes
F1
TECH transaction

Common Stock

Tax liability

Transaction value
$733,992
Shares
-8,675
Change %
-0.67%
Price
$84.61
Shares after
1,278,269
Date
15 Aug 2023
Ownership
Direct
Footnotes
F1
TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
400
Date
15 Aug 2023
Ownership
By Step-Son
TECH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
400
Date
15 Aug 2023
Ownership
By Step-Daughter

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+59,095
Change %
Price
$0.000000
Shares after
59,095
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
59,095
Exercise price
Footnotes
F3, F9
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
779,084
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
779,084
Exercise price
$31.26
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
361,336
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
361,336
Exercise price
$44.33
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
240,888
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
240,888
Exercise price
$44.33
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
342,900
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
342,900
Exercise price
$47.60
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
228,600
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
228,600
Exercise price
$47.60
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
66,600
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,600
Exercise price
$66.97
Footnotes
F2
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
299,768
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
299,768
Exercise price
$66.97
Footnotes
F2
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,268
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
52,900
Exercise price
Footnotes
F3, F4
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
153,180
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
153,180
Exercise price
$66.97
Footnotes
F5
TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
32,064
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,064
Exercise price
Footnotes
F3, F6
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
125,260
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,260
Exercise price
$120.46
Footnotes
F6
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
83,504
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
83,504
Exercise price
$120.46
Footnotes
F7
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
600,000
Date
15 Aug 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
600,000
Exercise price
$94.52
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Includes 7,128 shares of restricted stock for which the risk of forfeiture will lapse on August 6, 2024.

Footnote F2

Fully exercisable.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F4

17,636 shares vest on 8/15/2024 and 17,632 shares vest on 8/15/2025.

Footnote F5

Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.

Footnote F6

Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F7

Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.

Footnote F8

600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F9

19,698 shares vest on each of 8/15/2024 and 8/15/2026, and 19,699 shares vest on 8/15/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .